The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.
The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.

March 11, 2020: Recent Findings

Women in athletic wear sits holding apple.

Image Credit: JAMA Cardiology



FHS researchers quantified how time spent in good health affects you later in life.

Key Points
Question Is the length of time lived in ideal cardiovascular health in midlife associated with cardiometabolic outcomes or with all-cause mortality later in life?

Findings in this cohort study, using data from 1445 middle-aged participants from the Framingham Heart Study Offspring cohort, for each 5-year period that participants had intermediate or ideal cardiovascular health, they were 33% less likely to develop hypertension, 14% less likely to die, and approximately 25% less likely to develop diabetes, chronic kidney disease, or cardiovascular disease than individuals in poor cardiovascular health.

Meaning Living longer in better cardiovascular health during midlife may be associated with lower risk of chronic disease or mortality later in life.

Read full text online:
Corlin L, Short MI, Vasan RS, Xanthakis V. Association of the Duration of Ideal Cardiovascular Health Through Adulthood With Cardiometabolic Outcomes and Mortality in the Framingham Offspring Study. JAMA Cardiol. Published online March 11, 2020. doi:10.1001/jamacardio.2020.0109